The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Genentech/Roche
Consulting or Advisory Role - Galderma; LEO Pharma; Novartis; Pierre Fabre; Roche
Patents, Royalties, Other Intellectual Property - Genentech
Travel, Accommodations, Expenses - Galderma; LEO Pharma; Roche
 
Research Funding - Bristol-Myers Squibb (Inst); CSO Pharma (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Roche/Genentech (Inst)
Vismodegib (VISMO), a hedgehog pathway inhibitor (HPI), in advanced basal cell carcinoma (aBCC): STEVIE study primary analysis in 1215 patients (pts).
 
Johan Hansson
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche Pharma AG
Research Funding - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck Sharp & Dohme; Novartis; Roche
 
Axel Hauschild
Honoraria - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Celgene; Eisai; GlaxoSmithKline; MedImmune; MELA Sciences; Merck Serono; Merck Sharp & Dohme; Novartis; OncoSec; Roche
 
Rainer Kunstfeld
Honoraria - Meda Pharmaceuticals; Menarini; Novartis; Roche
Consulting or Advisory Role - LEO Pharma; Meda Pharmaceuticals; Menarini; Novartis; Roche; Sprig
 
Jean Jacques Grob
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; GlaxoSmithKline; Merck; Novartis; Roche
Speakers' Bureau - GlaxoSmithKline
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Brigitte Dréno
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Novartis; Roche
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Roche
 
Laurent Mortier
No Relationships to Disclose
 
Paolo Antonio Ascierto
Consulting or Advisory Role - Amgen; Array BioPharma; Bristol-Myers Squibb; Merck Sharp & Dohme; Novartis; Roche/Genentech; Ventana Medical Systems
Research Funding - Bristol-Myers Squibb (Inst); Roche/Genentech (Inst); Ventana Medical Systems (Inst)
 
Lisa F. Licitra
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Debiopharm Group; Eisai; GlaxoSmithKline; Merck Serono; MSD; Novartis; SOBI; VentiRx
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Eisai (Inst); Exelixis (Inst); Merck Serono (Inst); MSD (Inst); Novartis (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Bayer; Celgene; Debiopharm Group; Merck Serono; MSD; sobi
 
Caroline Dutriaux
Research Funding - Bristol-Myers Squibb (Inst); Roche (Inst)
 
Luc Thomas
Travel, Accommodations, Expenses - Roche
 
Nicolas Meyer
Honoraria - Bristol-Myers Squibb; Roche
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche
Expert Testimony - Amgen; Bristol-Myers Squibb; Roche
 
Bernard Guillot
Honoraria - Roche
Research Funding - Bristol-Myers Squibb (Inst); LEO Pharma (Inst); Roche (Inst)
 
Reinhard Dummer
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; MSD; Novartis; Roche
 
Petr Arenberger
No Relationships to Disclose
 
Kate Fife
Honoraria - GlaxoSmithKline; Roche
Consulting or Advisory Role - Roche
Research Funding - AstraZeneca (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Novartis; Roche
 
Ana Raimundo
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche
Speakers' Bureau - Bristol-Myers Squibb; MSD; Roche
 
Emi Dika
No Relationships to Disclose
 
Natalie Dimier
Employment - GlaxoSmithKline; Roche
Stock and Other Ownership Interests - GlaxoSmithKline
 
Ioannis Xynos
Employment - Roche
Stock and Other Ownership Interests - Roche
 
Nicole Basset-Seguin
No Relationships to Disclose